US FDA Outlines Psychedelic Drug Trial Principles, But It Won’t Be An Easy Trip

psychedelic drugs
Among the recommendations in the FDA's new psychedelic drugs guidance is that a REMS could be imposed with approval. • Source: Shutterstock

More from Clinical Trials

More from R&D